上海泽涵 生物医药科技有限公司 公司信息

公司名称: 上海泽涵 生物医药科技有限公司
电话: 021-021-61350663
电子邮件:sales@zehanbiopharma.com
国籍:中国
网址: http://www.zehanbiopharma.com
产品总数:991
3 4 5 6 7 8 9 10

公司提供产品列表

ODM203 ODM203 1430723-35-5
blu667 BLU-667(拉西替尼) 2097132-94-8
TAS-120 FGFR抑制剂(FGFR-IN-1) 1448169-71-8
ETC-1002 贝派地酸 738606-46-7
LOXO-195 LOXO-195 2097002-61-2
Derazantinib (ARQ 087) 德拉赞替尼 1234356-69-4
AZD0364 CS-2696 2097416-76-5
ML204 4-METHYL-2-(1-PIPERIDINYL)-QUINOLINE 5465-86-1
UNC0379 UNC0379 1620401-82-2
N6-cyclohexyl-N2-(2-methyl-4-morpholinophenyl)-9H-purine-2,6-diamine N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺 1246529-32-7
U-104 U-104 178606-66-1
3-Cyano-7-ethoxycoumarin 3-氰基-7-乙氧基香豆素 117620-77-6
3-(4-morpholino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)benzonitrile PF-06447475 1527473-33-1
JH-II-127 JH-II-127 1700693-08-8
MSX-122 MSX 122 897657-95-3
NIBR189 NIBR189 1599432-08-2
Isoxazole 9 (ISX-9) ISX 9 832115-62-5
SGC707 N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 1687736-54-4
XY1 N-2-萘基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲 1624117-53-8
Rogaratinib 罗加替尼 1443530-05-9
AT9283 AT9283 896466-04-9
HS1371 HS1371 2158197-70-5
ZL0420 化合物ZL0420 2229039-45-4
PQR309 Bimiralisib PI3K/MTOR抑制剂 1225037-39-7
IITZ-01 IITZ-01 1807988-47-1
GPR39-C3 CS-2374 1621175-65-2
PMPA(NAALADaseinhibitor) 2-(PHOSPHONOMETHYL)PENTANEDIOIC ACID 173039-10-6
E6005 E6005 947620-48-6
C188-9 432001-19-9 432001-19-9
SF-2523 SF-2523 1174428-47-7
HG-9-91-01 N-(2,4-二甲氧基苯基)-N'-(2,6-二甲基苯基)-N-[6-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]脲 1456858-58-4
Takinib 1111556-37-6 1111556-37-6
AR7 CS-2649 80306-38-3
5-(1-Methyl-1H-pyrazol-4-yl)-4-(4-morpholinyl)-7H-Pyrrolo[2,3-d]pyrimidine CS-2879 1527473-30-8
GSK GSK369796 1010411-21-8
Monastrol CS-2432 254753-54-3
HPI-4 HPI-4 302803-72-1
RS-1 4-溴-N-(4-溴苯基)-3-[[(苯基甲基)氨基]磺酰基]苯甲酰胺 312756-74-4
M2I-1 312271-03-7 312271-03-7
Bohemine BOHEMINE 189232-42-6
2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine hydrate trihydrochloride BIX 01294 935693-62-2
TA-01 TA 01 1784751-18-3
PCI 34051 N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺 950762-95-5
BMS-5 BMS-5 1338247-35-0
BMS-3 BMS-3 1338247-30-5
SP2509 无中文名称 1423715-09-6
N/A 4,4'-(pentane-1,5-diylbis(oxy))dibenzimidamide dihydrochloride 50357-35-4
BIIB057 HCl PRT062607 (HYDROCHLORIDE) 1370261-97-4
FK866 (E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide 1198425-96-5
SNX-5422 SNX-5422 908115-27-5
Ponesimod PONESIMOD 854107-55-4
Eniporide N-(二氨基亚甲基)-2-甲基-5-(甲基磺酰基)-4-(1H-吡咯-1-基)苯甲酰胺 176644-21-6
N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide GSK2981278 1474110-21-8
B-Raf inhibitor 1 dihydrochloride B-Raf 抑制剂 1 二盐酸盐 1191385-19-9
MSDC 0160 MSDC-0160 146062-49-9
Ki2 0227 Ki20227 623142-96-1
Nelonicline Nelonicline 1026134-63-3
Sparsentan (RE-021) 4'-[(2-丁基-4-氧代-1,3-二氮杂螺[4.4]壬-1-烯-3-基)甲基]-N-(4,5-二甲基-3-异恶唑基)-2'-(乙氧基甲基)-[1,1'-联苯]-2-磺酰胺 254740-64-2
Retro-2 2,3-DIHYDRO-2-(5-METHYL-2-THIENYL)-3-PHENYL-4(1H)-QUINAZOLINONE 1429192-00-6
Lipofermata 5-溴-5'-苯基-3'H-螺环[吲哚啉-3,2'-[1,3,4]噻二唑]-2-酮 297180-15-5
IWP-O1 IWP-O1 2074607-48-8
V-9302 V-9302 1855871-76-9
DC661 DC661 1872387-43-3
LIT-927 LIT-927游离 2172879-52-4
BAY-8002 2-(2-氯-5-(苯基磺酰基)苯甲酰氨基)苯甲酸 724440-27-1
Larotrectinib (LOXO-101 sulfate) (3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐 1223405-08-0
leniolisib(CDZ 173) LENIOLISIB 1354690-24-6
BAY1125976 CS-2913 1402608-02-9
Capromorelin 卡普瑞林 193273-66-4
FM381 (E)-2-CYANO-3-(5-(1-CYCLOHEXYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDIN-2-YL)FURAN-2-YL)-N,N-DIMETHYLACRYLAMIDE 2226521-65-7
CNX2006 CNX2006 1375465-09-0
MK-8353 (SCH900353) 化合物 T12069 1184173-73-6
Rocilinostat (ACY-1215) ACY1215 1316214-52-4
GSK2982772 GSK2982772 1622848-92-3
APY29 APY29 1216665-49-4
Autophinib 6-CHLORO-N-(5-METHYL-1H-PYRAZOL-3-YL)-2-(4-NITROPHENOXY)PYRIMIDIN-4-AMINE 1644443-47-9
SAR-20347 CPDD1211 1450881-55-6
R1487 SY-R1487 449808-64-4
SRT2104 (GSK2245840) 玻玛西林 1093403-33-8
AST487 AST 487 630124-46-8
PD-166285 6-(2,6-二氯苯基)-2-[[4-[2-(二乙基氨基)乙氧基]苯基]氨基]-8-甲基吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐 212391-63-4
Volitinib 沃利替尼 1313725-88-0
BBT594 BBT594 882405-89-2
Entospletinib (GS-9973) GS-9973 1229208-44-9
URMC-099 URMC-099 1229582-33-5
CP 640186 (R)-ANTHRACEN-9-YL(3-(MORPHOLINE-4-CARBONYL)-1,4'-BIPIPERIDIN-1'-YL)METHANONE.HCL 591778-68-6
GSK-3326595 GSK-3326595 1616392-22-3
4SC-202 tosylate 4SC-202(盐的形式) 1186222-89-8
LY2606368 dihydrochloride CHK1抑制剂 1234015-54-3
KO-947 KO-947 1695533-89-1
BLU-782 BLU-782 2141955-96-4
ARN-3236 3-(2,4-二甲氧基苯基)-4-(3-噻吩基)-1H-吡咯并[2,3-B]吡啶 1613710-01-2
M-2951 (Evobrutinib) 埃沃布鲁替尼 1415823-73-2
Avapritinib (BLU-285) 阿伐普替尼 1703793-34-3
Tomivosertib eFT508 6'-[(6-氨基-4-嘧啶基)氨基]-8'-甲基螺[环己烷-1,3'(2'H)-咪唑并[1,5-A]吡啶]-1',5'-二酮 1849590-01-7
MB-07811 ( VK-2809) MB-07811 852948-13-1
2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl] 化合物BET BROMODOMAIN INHIBITOR 1505453-59-7
ALK inhibitor 2 2-[[5-氯-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺 761438-38-4
Emedastine 依美斯汀 87233-61-2
SGI-1776 SGI-1776 1025065-69-3
3 4 5 6 7 8 9 10
Copyright 2007© ChemicalBook. All rights reserved.